3 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
in CVD and CKD ... in HF and CKD. ... in HFrEF on GDMT ... outcomes in HFrEF ... #table #CVD #CKD
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
angiotensin-receptor blocker; CAD ... ejection fraction; GDMT ... heart failure; HFpEF ... ejection fraction; HFrEF ... #CHF #Congestive
Iron Deficiency in Heart Failure
Pathophysiology:
Chronic heart failure leads to an increase in inflammatory cytokines → Inflammation
Iron Deficiency ... functional ID) Treatment ... #deficiency #CHF ... #HFrEF #heartfailure ... #diagnosis #management